Claudio Maria Mastroianni

Pubblicazioni

Titolo Pubblicato in Anno
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016 NEW MICROBIOLOGICA 2017
Novelties in Evaluation and Monitoring of Human Immunodeficiency Virus-1 Infection: Is Standard Virological Suppression Enough for Measuring Antiretroviral Treatment Success? AIDS REVIEWS 2017
Rate, correlates and outcomes of repeat pregnancy in HIV-infected women HIV MEDICINE 2017
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: data from the Icona cohort PLOS ONE 2017
The role of interferon-gamma release assays in predicting the emergence of active tuberculosis in the setting of biological treatment: a case report and review of the literature CLINICAL RHEUMATOLOGY 2016
Impact of switching from lopinavir/ritonavir to boosted and un-boosted atazanavir on glucose metabolism: ATAzanavir & GLUcose metabolism (ATAGLU) sudy INTERNATIONAL JOURNAL OF STD & AIDS 2016
Treatment of latent tuberculosis infection induces changes in multifunctional Mycobacterium tuberculosis-specific CD4(+) T cells MEDICAL MICROBIOLOGY AND IMMUNOLOGY 2016
Blood myeloid dendritic cells and slandc in antiretroviral therapy-suppressed hiv-infected patients CURRENT HIV RESEARCH 2016
Rapid decline of fasting glucose in HCV diabetic patients treated with direct-acting antiviral agents CLINICAL MICROBIOLOGY AND INFECTION 2016
Liver fibrosis in HCV monoinfected and HIV/HCV coinfected patients: dysregulation of matrix metalloproteinases (MMPs) and their tissue inhibitors TIMPs and effect of HCV protease inhibitors INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2016
Pseudo-outbreak of Mycobacterium gordonae in a teaching hospital: importance of strictly following decontamination procedures and emerging issues concerning sterilization NEW MICROBIOLOGICA 2016
Severe bloodstream infection due to KPC-producer e coli in a renal transplant recipient treated with the double-carbapenem regimen and analysis of in vitro synergy testing a case report MEDICINE 2016
Role of sonication in the microbiological diagnosis of implant-associated infections: Beyond the orthopedic prosthesis ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 2016
Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae CLINICAL MICROBIOLOGY AND INFECTION 2016
Surgical site infection after caesarean section. Space for post-discharge surveillance improvements and reliable comparisons NEW MICROBIOLOGICA 2016
Natalizumab affects T-cell phenotype in multiple sclerosis: implications for JCV reactivation PLOS ONE 2016
Archetype and rearranged non-coding control regions (NCCR) in urothelial bladder carcinoma of immunocompetent individuals CANCER GENOMICS & PROTEOMICS 2016
Nursing home residence is associated with spread of Clostridium difficile ribotype 027 in central Italy THE JOURNAL OF HOSPITAL INFECTION 2016
Herpes virus reactivation after initiation of interferon-free antiviral agents in HIV-HCV-coinfected subjects: a new immune restoration disease? ANTIVIRAL THERAPY 2016
Abstracts of ICI 2016 International Congress of Immunology, 21-26 August 2016, Melbourne, Australia EUROPEAN JOURNAL OF IMMUNOLOGY 2016

ERC

  • LS6
  • LS6_6
  • LS6_8
  • LS6_9
  • LS6_11

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

Infezione da HIV, Tubercolosi, Infezioni del SNC, COVID-19, Terapie innovative delle malattie infettive, antimicrobico resistenza, Studio delle interazioni tra sistema immunitario e infezioni, Infezioni correlate all'assistenza sanitaria, Patogenesi delle infezioni virali

Keywords

antiretroviral therapy hiv
antimicrobial combinations
2019 novel coronavirus
tuberculosis
Bacterial Infections
innate immunity
antimicrobial resistance

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma